UNCTAD Handbook: IP And The CBD Protocol On Genetic Resources 30/04/2013 by Catherine Saez, Intellectual Property Watch 1 Comment The Nagoya Protocol, adopted under the Convention on Biological Diversity, provides a set of rules to prevent misappropriation of genetic resources. As such, it crosses paths with the international intellectual property system. This interface is the subject of a handbook to be published by the United Nations Conference on Trade and Development.
UNCTAD: IPRs In Health, Research, Cosmetics, Meet Access & Benefit Sharing 29/04/2013 by Catherine Saez, Intellectual Property Watch 2 Comments The interactions between intellectual property and international rules of global access and benefit sharing were explored recently as an expert group meeting was convened by the United Nations Conference on Trade and Development (UNCTAD) to explore several areas where those interactions occur.
New WIPO Text On Traditional Knowledge Protection Cleaner But Issues Remain 28/04/2013 by Catherine Saez, Intellectual Property Watch 5 Comments The main goal has been achieved for World Intellectual Property Organization delegates who started last week with the task of improving a document to become an international instrument protecting traditional knowledge. Consensus has not been met on core issues, but a cleaner text has emerged, reflecting a clearer understanding of positions, sources said.
Industry List Of Potential US GIs Released Ahead Of WIPO Meeting 27/04/2013 by Catherine Saez, Intellectual Property Watch Leave a Comment A producers’ group lobbying in favour of geographical indications has issued a preliminary list of candidate GIs in the United States. The list, released just prior to a World Intellectual Property Organization negotiation on a possible instrument on GIs, takes a particular look at American wines.
US Supreme Court May Invalidate Gene Patents, But Create Little Change 23/04/2013 by Steven Seidenberg for Intellectual Property Watch Leave a Comment Prior to 15 April, most experts had expected the United States Supreme Court to rule in Association for Molecular Pathology v. Myriad Genetics that genes cannot be patented. The oral argument on that date strengthened this consensus opinion, but also suggested that the court would issue a narrow decision which would allow many types of gene-related patents. Should this happen, the US would move significantly closer to other countries’ rules for gene patents, but the US would continue to have problems limiting patent rights in order to protect the public interest.
Rethinking The Role Of Innovation In The Green Technologies Context 23/04/2013 by Tiphaine Nunzia Caulier for Intellectual Property Watch Leave a Comment European Union (EU) Commissioner for Environment, Janez Potocnik, during a recent visit to Geneva, elaborated on the global challenges the world faces and on the strategic choices they impose, with a regional focus on Europe. He said the rise in human population that we will observe in the upcoming years raises questions regarding the management of natural resources. In that respect, Potocnik explained the need to rethink our current economic system and the way innovation is carried out.
Greek Gene Bank’s Struggle Indicative Of Changing Times 17/04/2013 by Paraskevi Kollia for Intellectual Property Watch 3 Comments Gene banks holding plant genetic material worldwide play a crucial role for future agricultural practices and research and development in the field, especially as people rediscover the importance of their dependence on the land due to the financial situation. The present financial crisis may generate opportunities and losses. This can be illustrated by the Gene Bank of Greece, an institution traditionally rich in genetic material and of global interest.
The Novartis Decision: A Tale Of Developing Countries, IP, And The Role Of The Judiciary 15/04/2013 by Intellectual Property Watch 2 Comments Ahmed Abdel Latif says of the Novartis case: The ruling is also a revealing tale about the changing role of developing countries in the global intellectual property landscape and the growing influence of the judiciary in these countries in the implementation of international intellectual property rules.
Reports: Obama’s Proposed 2014 Budget Favours Patent Office, R&D, Generic Drugs 11/04/2013 by William New, Intellectual Property Watch 1 Comment US President Barack Obama yesterday released his proposed budget for fiscal year 2014, and according to reports it would give the US Patent and Trademark Office (USPTO) control over its revenues, and would be mixed for the biopharmaceutical industry while taking several steps to boost generic medicines.
WIPO Hails India’s Accession To Trademark System; India Advocates Balance 09/04/2013 by Catherine Saez, Intellectual Property Watch 1 Comment A full room of country delegates and ambassadors gathered yesterday to celebrate the accession of India to the Madrid Protocol for the International Registration of Marks at the World Intellectual Property Organization. However, beyond the joy of accession, the recent decision of the Indian Supreme Court on a Novartis drug patent loomed in the room.